Refractive surgery techniques could raise IOP and lead to glaucoma

Article

The risk of glaucoma after refractive surgery procedures should not be underestimated, claims José Belda, MD, speaking at the Alicante Refractiva International meeting, held March 6–8 in Spain.

The risk of glaucoma after refractive surgery procedures should not be underestimated, claims José Belda, MD, speaking at the Alicante Refractiva International meeting, held March 6–8 in Spain.

Dr Belda, of Vissum Institute in Alicante, said that, as the volume of refractive surgery is constantly increasing, and that the largest part of refractive surgery procedures are performed in myopic patients, amongst whom the prevalence of glaucoma is three- to four-times higher than normal, there may be a large quantity of patients presenting this problem in the future.

True intraocular pressure (IOP) levels are difficult to assess after surgery, regardless of the technique used: this can lead to IOP being underestimated, which results in glaucoma going undiagnosed for a long time. Each technique, however, can have additional problems of its own. For example, the high levels of corticosteroids used with surface techniques may lead to corticosteroid-induced glaucoma, particularly in patients with high myopia, while the pressure values during the vacuum phase of LASIK procedures can reach as high as 200 mmHg. Furthermore, the extra length of a femtosecond procedure can cause damage to the optic nerve because of the longer time that the cornea is flattened. It has not yet been proved whether this pressure increase is safe in eyes with underlying glaucoma or ocular hypertension.

Dr Belda concluded by saying that he believed that most cases of glaucoma after refractive surgery are related to corticosteroid-induced increases in IOP.

Related Videos
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
Giulia Corradetti, MD, discusses her presentation "Functional Microperimetric Correlates of OCT Structures Features in Intermediate AMD"
At this year's ARVO meeting, Paolo Silva, MD, presented data on Protocol AA on behalf of the DRCR Retina Network
Baruch Kuppermann, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.